---
id: 20260702-T0-12
title: "Genesis分子AI访谈：为何Llama负责人离职Meta转做药物研发"
title_en: "Genesis AI: Why Llama Lead Left Meta for Drug Discovery"
url: https://ai.daily.yangsir.net/daily/20260702-T0-12
issue_date: 2026-07-02
publish_date: 2026-07-01T14:42:39.000Z
category: news
source_name: "Latent Space"
source_url: https://www.latent.space/p/the-coolest-diffusion-research-isnt
---

# Genesis分子AI访谈：为何Llama负责人离职Meta转做药物研发

前 Meta Llama 项目负责人 Evan Feinberg 与 Sergey Edunov 成立了 Genesis Molecular AI。他们分享了离开大模型主流赛道转向药物研发的深层原因，讨论了 PEARL 模型在零样本 OpenBind 任务上的胜利，以及当共折叠技术最终跨越精度阈值后所开启的生物学新可能。

## English Version

**Genesis AI: Why Llama Lead Left Meta for Drug Discovery**

Former Meta Llama lead Evan Feinberg and Sergey Edunov discuss their shift from LLMs to drug discovery at Genesis Molecular AI. Key topics include PEARL's zero-shot win on OpenBind and the new possibilities unlocked as co-folding accuracy thresholds are crossed.

---

**来源**：[Latent Space](https://www.latent.space/p/the-coolest-diffusion-research-isnt)

**详情页**：https://ai.daily.yangsir.net/daily/20260702-T0-12

---

*智语观潮 · Daily — https://ai.daily.yangsir.net/llms.txt*